CD8A and neoplasm: Additionally, Treg cells have been shown to inhibit the production of costimulatory ligands necessary for the activation of CD8+ T cells by restricting the immunogenic functions of tumor-associated CD11c+ dendritic cells (DCs), thereby limiting CD8+ T cell responses (25).